Syrs news

Author: furq

August undefined, 2024

WebMar 29, 2024 · Get Syros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SYRS and its competitors with MarketBeat's FREE … WebAt Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing new …

Syros Pharmaceuticals Inc SYRS Stock Quote - NASDAQ

WebApr 15, 2024 · NASDAQ SYRSopened at $2.70 on Friday. The stock has a market capitalization of $54.81 million, a PE ratio of -0.21 and a beta of 1.67. The business has a … WebJul 5, 2024 · (RTTNews) - Syros Pharmaceuticals (SYRS) and TYME Technologies, Inc. (TYME) announced that the companies have entered into a definitive merger agreement pursuant to which Syros will acquire TYME,... may 1999 commercials

Syros Pharmaceuticals, Inc. (SYRS) - Stock Analysis

WebMar 17, 2024 · The latest price target for Syros Pharmaceuticals ( NASDAQ: SYRS) was reported by Oppenheimer on Friday, March 3, 2024. The analyst firm set a price target for 13.00 expecting SYRS to rise to... WebJul 12, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ: SYRS)'s merger with TYME Technologies, Inc. ... More news releases in similar topics. Contact Cision. Cision Distribution 888-776-0942 from 8 AM - 9 PM ET ... WebApr 10, 2024 · Support: 888-992-3836 Home NewsWire Subscriptions ... herringer catalog

Syros Pharmaceuticals Stock (NASDAQ:SYRS): Worse than a …

Syros to Participate in Upcoming Investor Conferences in March

WebApr 15, 2024 · Syros Pharmaceuticals Trading Down 2.5 %. Shares of Syros Pharmaceuticals stock opened at $2.70 on Friday. The firm has a market capitalization of … WebSyros Pharmaceuticals, Inc. (SYRS) Latest Stock News & Headlines - Yahoo Finance U.S. markets closed Dow Futures Nasdaq Futures Russell 2000 Futures (+0.25%) Crude Oil … Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call Transcript Ma… Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock discussion in Yahoo Fina… herring equipmentWebView today's SYRS stock price, trade commission-free, and discuss SYRS stock updates with the investor community. ... Discuss news and analysts' price predictions with the investor community. Start investing. Invest in SYRS. Order type. Invest in. Shares Dollars. Amount. Market price $2.59. herring elementary

"Web1 day ago · Zacks News for SYRS Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates 03/02/23-8:35AM EST Zacks " - Syrs news

Syrs news

SYRS (Syros Pharmaceuticals) Operating Income

WebSYRS : 1.0200 (-5.56%) Syros to Report First Quarter 2024 Financial Results on Monday, May 16, 2024 Business Wire - Mon May 9, 6:30AM CDT. Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET... WebDec 5, 2024 · December 5, 2024 - 7:00 am. CAMBRIDGE, Mass. Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a virtual event to discuss initial data from the safety lead-in portion of the ongoing Phase 2 SELECT-AML-1 clinical trial and to review the …

Did you know?

WebSYRS Complete Syros Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Skip to main content Main Menu WebSyros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA. Show more Ideas

WebSyros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the grant of restricted stock unit (RSU) awards for an aggregate of 14,200... SYRS : 2.51 (-2.15%) Syros Pharmaceuticals Announces Publication in Blood Advances Demonstrating the Potential of Tamibarotene … Web1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Syros Pharmaceuticals (SYRS)

WebSyros Pharmaceuticals Inc. (SYRS) Stock Price Today, News, Quotes, FAQs and Fundamentals DIA 0.42% SPY 0.17% QQQ 0.55% Trending RIOT 14.56% AUPH 10.18% … WebSyros Pharmaceuticals…. Syros Pharmaceuticals presents safety lead-in data from SELECT-AML-1 trial » 12/11/22. SYRS. Syros Pharmaceuticals…. Syros Pharmaceuticals price target lowered to $16 from $40 at JMP Securities » 11/15/22. SYRS. JMP Securities analyst…. Syros Pharmaceuticals price target lowered to $15 from $30 at Oppenheimer ...

WebApr 7, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. …

WebFeb 2, 2024 · The U.S. Food and Drug Administration granted orphan drug designation to Syros Pharmaceuticals' (SYRS) tamibarotene to treat myelodysplastic syndrome ((MDS)).Tamibarotene is... may 1997 interview ramseyWebThe Latest News and Updates in National News brought to you by the team at WSYR: may 1997 sesame street elmo says boo dvdWebApr 9, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) posted its quarterly earnings data on Thursday, March, 2nd. The company reported ($1.28) EPS for the quarter, missing the … may 19 birthdays famous people